BIT
NBSE

BlackRock Institutional Trust’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

BlackRock Institutional Trust’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$644K Hold
1,074
– – ﹤0.01% 3407
2016
Q3 		$1.22M Hold
1,074
– – ﹤0.01% 3224
2016
Q2 		$1.18M Sell
1,074
-45
-4% -$56.5K ﹤0.01% 3252
2016
Q1 		$1.44M Sell
1,119
-8
-0.7% -$11.4K ﹤0.01% 3171
2015
Q4 		$2.77M Buy
1,127
+145
+15% +$223K ﹤0.01% 2982
2015
Q3 		$1.08M Buy
982
+934
+1,946% +$1.08M ﹤0.01% 3320
2015
Q2 		$48K Sell
48
-428
-90% -$462K ﹤0.01% 3786
2015
Q1 		$484K Buy
476
+2
+0.4% +$6.6K ﹤0.01% 3513
2014
Q4 		$1.58M Sell
474
-11
-2% -$33.7K ﹤0.01% 3208
2014
Q3 		$1.41M Buy
485
+5
+1% +$16.5K ﹤0.01% 3212
2014
Q2 		$1.83M Buy
480
+465
+3,100% +$1.75M ﹤0.01% 3231
2014
Q1 		$80K Buy
15
+12
+400% +$63.2K ﹤0.01% 3789
2013
Q4 		$11K Buy
+3
New +$9.25K ﹤0.01% 3925

Other funds holding NBSE

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

BlackRock Institutional Trust's NBSE Position: Q4 2016 in Review

BlackRock Institutional Trust held its NeuBase Therapeutics, Inc. Common Stock (NBSE) position steady in Q4 2016 at 1,074 shares worth $644K. The position accounts for ﹤0.01% of the portfolio, ranked #3407.

BlackRock Institutional Trust first reported a position in NBSE in Q4 2013 and has held it in 13 quarters since. The position peaked at $2.77M in Q4 2015. 49 funds tracked by Wall St. Rank hold NBSE as of Q4 2016.

  • BlackRock Institutional Trust held 1,074 shares of NeuBase Therapeutics, Inc. Common Stock worth $644K as of Q4 2016.
  • BlackRock Institutional Trust left its NeuBase Therapeutics, Inc. Common Stock share count unchanged in Q4 2016.
  • NeuBase Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3407 holding.
  • BlackRock Institutional Trust first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q4 2013 and has held it in 13 quarters since.
  • BlackRock Institutional Trust's NeuBase Therapeutics, Inc. Common Stock position peaked at $2.77M in Q4 2015.
  • 49 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.